{
    "2019-02-27": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Veeva Systems (VEEV) Beats on Q4 Earnings and Revenues",
                "features": {
                    "keywords": [
                        "Veeva",
                        "Q4",
                        "Earnings",
                        "Revenues",
                        "Beats"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-02",
                "original_text": "Wright Medical (WMGI) Q4 Earnings & Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Wright",
                        "Medical",
                        "Q4",
                        "Earnings",
                        "Revenues",
                        "Beat",
                        "Estimates"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-03",
                "original_text": "Report: Developing Opportunities within Abbott Laboratories, American Express, Welbilt, Cinemark, Barnes Group, and Nevsun Resources â€” Future Expectations, Projections Moving into 2019",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Laboratories",
                        "American",
                        "Express",
                        "Welbilt",
                        "Cinemark",
                        "Barnes",
                        "Group",
                        "Nevsun",
                        "Resources",
                        "Opportunities",
                        "Expectations",
                        "Projections"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-04",
                "original_text": "Here's Why Investors Should Buy DexCom (DXCM) Stock Now",
                "features": {
                    "keywords": [
                        "Investors",
                        "Buy",
                        "DexCom",
                        "Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-05",
                "original_text": "Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts",
                "features": {
                    "keywords": [
                        "Bruker",
                        "Robust",
                        "NANO",
                        "CALID",
                        "Groups",
                        "Buyouts"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "scientific instruments",
                        "life sciences"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}